{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:59:34Z","timestamp":1776448774397,"version":"3.51.2"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ucl.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:24:33Z","timestamp":1773491073000},"page":"205-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical Management of High-Risk Prostate Cancer"],"prefix":"10.1016","volume":"53","author":[{"given":"Joseph G.","family":"Cheaib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad E.","family":"Allaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ucl.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.urology.2012.07.040","article-title":"Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system","volume":"80","author":"Reese","year":"2012","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.eururo.2019.12.017","article-title":"Active Surveillance of Grade Group 1 prostate cancer: long-term outcomes from a large prospective cohort","volume":"77","author":"Tosoian","year":"2020","journal-title":"Eur Urol"},{"issue":"17","key":"10.1016\/j.ucl.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ucl.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.eururo.2016.11.006","article-title":"New prostate cancer grading system predicts long-term survival following surgery for gleason score 8\u201310 prostate cancer","volume":"71","author":"Ham","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cncr.31833","article-title":"Outcomes of very high-risk prostate cancer after radical prostatectomy: validation study from 3 centers","volume":"125","author":"Sundi","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/pros.24261","article-title":"Effects of the 2012 and 2018 US preventive services task force prostate cancer screening guidelines on pathologic outcomes after prostatectomy","volume":"82","author":"Plambeck","year":"2022","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.ucl.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bju.15051","article-title":"Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience","volume":"125","author":"Seetharam Bhat","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.critrevonc.2016.04.011","article-title":"High-risk prostate cancer: the role of surgical management","volume":"102","author":"Morlacco","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.ucl.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41585-020-00384-7","article-title":"Surgical management of high-risk, localized prostate cancer","volume":"17","author":"Wilkins","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11864-023-01162-4","article-title":"Surgical management and considerations for patients with localized high-risk prostate cancer","volume":"25","author":"Fang","year":"2024","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/pcan.2017.5","article-title":"Contemporary management of men with high-risk localized prostate cancer in the United States","volume":"20","author":"Weiner","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990\u20132013","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ucl.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN Clinical Practice Guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"9660","key":"10.1016\/j.ucl.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): an open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"issue":"9809","key":"10.1016\/j.ucl.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ucl.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2014.57.8724","article-title":"Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer: long-term quality-of-life outcomes from the NCIC CTG PR3\/MRC PR07 randomized trial","volume":"33","author":"Brundage","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ucl.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ejca.2005.11.030","article-title":"Radical prostatectomy for locally advanced prostate cancer: results of a feasibility study (EORTC 30001)","volume":"42","author":"Van Poppel","year":"2006","journal-title":"Eur J Cancer"},{"issue":"24","key":"10.1016\/j.ucl.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical prostatectomy or watchful waiting in prostate cancer \u2014 29-year Follow-up","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/bju.14987","article-title":"The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression","volume":"125","author":"Bryant","year":"2020","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2020.02.009","article-title":"Radical prostatectomy or observation for clinically localized prostate cancer: extended Follow-up of the prostate cancer intervention versus observation trial (PIVOT)","volume":"77","author":"Wilt","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ucl.2026.02.003_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6562","article-title":"Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer","volume":"2","author":"Jayadevappa","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"58","key":"10.1016\/j.ucl.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"99057","DOI":"10.18632\/oncotarget.21519","article-title":"Comparisons of health-related quality of life among surgery and radiotherapy for localized prostate cancer: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.ucl.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/cncr.23767","article-title":"Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng\/mL","volume":"113","author":"Inman","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/bju.16027","article-title":"Definitive local therapy for T4 prostate cancer associated with improved local control and survival","volume":"132","author":"Andring","year":"2023","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0090-4295(98)00616-5","article-title":"CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group","volume":"53","author":"Klotz","year":"1999","journal-title":"Urology"},{"issue":"26","key":"10.1016\/j.ucl.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1200\/JCO.20.00315","article-title":"CALGB 90203 (alliance): radical prostatectomy with or without neoadjuvant chemohormonal therapy in localized, high-risk prostate cancer","volume":"38","author":"Eastham","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/JU.0000000000002803","article-title":"Neoadjuvant novel hormonal therapy followed by prostatectomy versus Up-Front prostatectomy for high-risk prostate cancer: a comparative analysis","volume":"208","author":"Ravi","year":"2022","journal-title":"J Urol"},{"issue":"6_suppl","key":"10.1016\/j.ucl.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"TPS285","DOI":"10.1200\/JCO.2022.40.6_suppl.TPS285","volume":"40","author":"Kibel","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.urology.2007.02.054","article-title":"Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer","volume":"69","author":"Loeb","year":"2007","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.ucl.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.urolonc.2016.03.002","article-title":"Early oncological and functional outcomes following radical treatment of high-risk prostate cancer in men older than 70 years: a prospective longitudinal study","volume":"34","author":"Paterson","year":"2016","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2012.05.046","article-title":"Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy","volume":"62","author":"Ficarra","year":"2012","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2012.05.045","article-title":"Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy","volume":"62","author":"Ficarra","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.euo.2024.04.018","article-title":"Functional outcomes and quality of life in high-risk prostate cancer patients treated by robot-assisted radical prostatectomy with or without adjuvant treatments","volume":"8","author":"Devlies","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bju.14780","article-title":"Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment","volume":"124","author":"Reichard","year":"2019","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.ucl.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2017.75.9134","article-title":"Brachytherapy-based radiotherapy and radical prostatectomy are associated with similar survival in high-risk localized prostate cancer","volume":"36","author":"Ennis","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/JU.0000000000002250","article-title":"Survival after radical prostatectomy versus radiation therapy in high-risk and very high-risk prostate cancer","volume":"207","author":"Chierigo","year":"2022","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.eururo.2018.10.032","article-title":"Comparative effectiveness of radical prostatectomy versus external beam radiation therapy plus brachytherapy in patients with high-risk localized prostate cancer","volume":"75","author":"Berg","year":"2019","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.ucl.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"574.e11","DOI":"10.1016\/j.urolonc.2019.06.005","article-title":"Comparative effectiveness of treatments for high-risk prostate cancer patients","volume":"37","author":"Jayadevappa","year":"2019","journal-title":"Urol Oncol"},{"issue":"9","key":"10.1016\/j.ucl.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with gleason score 9\u201310 prostate cancer","volume":"319","author":"Kishan","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eururo.2018.02.012","article-title":"Effect of prostate cancer severity on functional outcomes after localized treatment: comparative effectiveness analysis of surgery and radiation study results","volume":"74","author":"Tyson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.euros.2022.04.013","article-title":"Characteristics of patients in SPCG-15\u2014A randomized trial comparing radical prostatectomy with primary radiotherapy plus androgen deprivation therapy in men with locally advanced prostate cancer","volume":"41","author":"Gongora","year":"2022","journal-title":"Eur Urol Open Sci"},{"issue":"Suppl 3","key":"10.1016\/j.ucl.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/1475-6773.13706","article-title":"Patterns of adoption of robotic radical prostatectomy in the United States and England","volume":"56","author":"Maynou","year":"2021","journal-title":"Health Serv Res"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1464-410x.2001.00115.x","article-title":"Robotically-assisted laparoscopic radical prostatectomy","volume":"87","author":"Binder","year":"2001","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.urolonc.2010.11.018","article-title":"Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer","volume":"31","author":"Rogers","year":"2013","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/end.2010.0349","article-title":"Robotic radical prostatectomy in patients with high-risk disease: a review of short-term outcomes from a high-volume center","volume":"25","author":"Jayram","year":"2011","journal-title":"J Endourol"},{"issue":"11","key":"10.1016\/j.ucl.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1464-410X.2010.09484.x","article-title":"Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer","volume":"106","author":"Wambi","year":"2010","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eururo.2015.06.020","article-title":"Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients","volume":"68","author":"Abdollah","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(16)30592-X","article-title":"Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study","volume":"388","author":"Yaxley","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ucl.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.21037\/tau.2019.12.01","article-title":"Comparative effectiveness of robotic and open radical prostatectomy","volume":"10","author":"Pessoa","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-5347(05)00340-X","article-title":"Robotic extraperitoneal radical prostatectomy: an alternative approach","volume":"175","author":"Joseph","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/end.2016.0706","article-title":"Extraperitoneal vs transperitoneal robot-assisted radical prostatectomy in the setting of prior abdominal or pelvic surgery","volume":"31","author":"Horovitz","year":"2017","journal-title":"J Endourol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12894-017-0298-z","article-title":"New steps of robot-assisted radical prostatectomy using the extraperitoneal approach: a propensity-score matched comparison between extraperitoneal and transperitoneal approach in Japanese patients","volume":"17","author":"Kurokawa","year":"2017","journal-title":"BMC Urol"},{"key":"10.1016\/j.ucl.2026.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2023.1157528","article-title":"Complications of extraperitoneal robot-assisted radical prostatectomy in high-risk prostate cancer: a single high-volume center experience","volume":"10","author":"Paladini","year":"2023","journal-title":"Front Surg"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.eururo.2010.06.008","article-title":"A new anatomic approach for robot-assisted laparoscopic prostatectomy: a feasibility study for completely intrafascial surgery","volume":"58","author":"Galfano","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/bju.14468","article-title":"Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) vs standard RARP: it\u2019s time for critical appraisal","volume":"123","author":"Stonier","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/bju.14887","article-title":"Retzius-sparing robot-assisted radical prostatectomy vs the standard approach: a systematic review and analysis of comparative outcomes","volume":"125","author":"Checcucci","year":"2020","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ucl.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00345-019-02798-4","article-title":"Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis","volume":"38","author":"Phukan","year":"2020","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2051415817706635","article-title":"Urinary continence four weeks following Retzius-sparing robotic radical prostatectomy: the UK experience","volume":"11","author":"Eden","year":"2018","journal-title":"J Clin Urol"},{"issue":"2","key":"10.1016\/j.ucl.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bju.12705","article-title":"Retzius-sparing robot-assisted laparoscopic radical prostatectomy: combining the best of retropubic and perineal approaches","volume":"114","author":"Lim","year":"2014","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.ucl.2026.02.003_bib62","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/iju.13808","article-title":"Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: analysis of 359 cases with a median follow-up period of 26 months","volume":"25","author":"Abdel","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.ucl.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euros.2022.02.007","article-title":"Retzius-sparing robot-assisted radical prostatectomy in high-risk prostate cancer patients: results from a large single-institution series","volume":"38","author":"Dell\u2019Oglio","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.ucl.2026.02.003_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2023.107168","article-title":"Study protocol for a prospective, multi-centered randomized controlled trial comparing pelvic fascia-sparing radical prostatectomy with conventional robotic-assisted prostatectomy: the PARTIAL trial","volume":"128","author":"Stangl-Kremser","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ucl.2026.02.003_bib65","first-page":"541","article-title":"Retzius-sparing robotic-assisted prostatectomy: technical challenges for surgeons and key prospective refinements","volume":"15","author":"Ferretti","year":"2023","journal-title":"Res Rep Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.juro.2017.12.037","article-title":"The effect of nerve sparing status on sexual and urinary function: 3-year results from the CEASAR study","volume":"199","author":"Avulova","year":"2018","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.eururo.2014.10.011","article-title":"Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery","volume":"67","author":"Steineck","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bju.14655","article-title":"An updated approach to incremental nerve sparing for robot-assisted radical prostatectomy","volume":"124","author":"Martini","year":"2019","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/end.2017.0701","article-title":"MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy","volume":"32","author":"Schiavina","year":"2018","journal-title":"J Endourol"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bju.16126","article-title":"Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre study","volume":"133","author":"Furrer","year":"2024","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2026.02.003_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41391-020-00266-4","article-title":"Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer","volume":"224","author":"Preisser","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.ucl.2026.02.003_bib73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2012.04.057","article-title":"Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11069 consecutive patients","volume":"62","author":"Schlomm","year":"2012","journal-title":"Eur Urol"},{"issue":"24","key":"10.1016\/j.ucl.2026.02.003_bib74","first-page":"00290","article-title":"Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during radical prostatectomy: a systematic review and meta-analysis","volume":"S2588-9311","author":"Kroon","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2026.02.003_bib75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(25)00091-9","article-title":"Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trial","volume":"26","author":"Dinneen","year":"2025","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2026.02.003_bib76","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00345-017-2134-1","article-title":"Complete bladder neck preservation promotes long-term post-prostatectomy continence without compromising midterm oncological outcome: analysis of a randomised controlled cohort","volume":"36","author":"Nyarangi-Dix","year":"2018","journal-title":"World J Urol"},{"issue":"12","key":"10.1016\/j.ucl.2026.02.003_bib77","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3390\/jcm8122068","article-title":"Effect of bladder neck preservation on long-term urinary continence after robot-assisted laparoscopic prostatectomy: a systematic review and meta-analysis","volume":"8","author":"Kim","year":"2019","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.ucl.2026.02.003_bib78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11934-017-0745-0","article-title":"Systematic review of studies reporting positive surgical margins after bladder neck sparing radical prostatectomy","volume":"18","author":"Bellangino","year":"2017","journal-title":"Curr Urol Rep"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014326000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014326000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:22:35Z","timestamp":1776446555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014326000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0094014326000030"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2026.02.003","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Management of High-Risk Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}